News for Epizyme, Inc. (EPZM)

HUTCHMED (China) Ltd (HCM) announced on March 21, 2025, that its New Drug Application for TAZVERIK® (tazemetostat) has received conditional approval from the N

”” First and only EZH2 inhibitor approved by the NMPA ”” ”” HUTCHMED's fourth product, and its first approval in hematological malignancies ”” HONG KO

PR NewswireCAMBRIDGE, Mass., Feb. 27, 2025 Topline pivotal data expected in 2025 for both TKI pre-treated ROS1-positive and TKI pre-treated ALK-positive NS

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today ann

PR NewswireCAMBRIDGE, Mass., Dec. 9, 2024 CAMBRIDGE, Mass., Dec. 9, 2024 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical

Epigenetics Market size was valued at USD 1.6 billion in 2023 to USD 4.7 billion by 2031, growing at a CAGR of 14.8% in the forecast period (2024-2031)....

Employee of French drugmaker Ipsen to plead guilty to US insider trading

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Epigenetics Diagnostic...

THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt as to the action to be taken, please seek your own financial advice from...

BOSTON and PLEASANTON, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing...

Aug 09, 2021 / 01:30PM GMTOperator Welcome to the HUTCHMED Company Update. I will now hand the session to Mr. Christian Hogg, CEO of HUTCHMED, to begin today's

/PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the 2023 Prix Galien...

The emergence of new products in the pipeline will add to the soft tissue sarcoma market growth in the future. In addition, persistently rising cases of...

/PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the 2023 Prix Galien...

Global Alpers Disease Treatment Market Size Poised To Reflect USD 1.90 billion Billion Mark by 2030. The key market players are listed in the report with...

The prevalence of mesothelioma has been rising over the past few years, which prompts the growing demand for treatment options. The increasing prevalence...

I tried to cross-tally the list of funds and companies banned by the Texas Comptroller with the publicly available holdings of Texan state pension funds. I found little overlap. I wonder whether the banned list was even meant to bite.

Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company.

This article focuses on the influences towards a biotech company's share price, rather than their value. Read what to know about biotech catalysts here.